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The human SIRT3 gene contains an intronic VNTR enhancer whose variability is correlated with life span. The SIRT3 5′ flanking region
encompasses the PSMD13 gene encoding the p40.5 regulator subunit of the 26S proteasome. Proteasome is a multicatalytic proteinase whose
function declines with aging. SIRT3 and PSMD13 are linked in a head-to-head configuration (788-bp intergenic region). The molecular
configuration of two genes that are both related to aging prompted us to search for shared regulatory mechanisms between them. Transfection
experiments carried out in HeLa cells by deletion mutants of the PSMD13–SIRT3 intergenic region showed a complex pathway of coregulation
acting in both directions. Furthermore, linkage disequilibrium (LD) analyses carried out in a sample of 710 subjects (18–108 years of age)
screened for A21631G (marker of PSMD13), and for G477T and VNTRintron5 (markers of SIRT3), revealed high LD, with significantly different
PSMD13–SIRT3 haplotype pools between samples of centenarians and younger people.
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pathways affecting aging and life span are evolutionarily
conserved [1,2]. Usually the conservation of aging-related paths
is interpreted in terms of pleiotropic phenomena [3]; however,
the significance of the evolutionary conservation of the paths is
still under discussion [4,5]. In this frame, the evolutionarily
conserved sirtuin 2 (SIR2) gene family is especially interesting.
First, in model organisms the expression levels of SIR2
modulate life span [6,7]; second, low-calorie diets that extend
life span also promote sirtuin activity, showing that sirtuins may
connect metabolism and aging [8]; third, Sir2 proteins exhibit
nicotinamide dinucleotide phosphate (NAD+)-dependent dea-
cetylase activity that could account for the broad range of
biological processes in which such proteins play a role,
including gene expression, metabolism, and aging [9].
The SIRT3 gene (11p15.5) is a human homologue of SIR2
genes [10] that is expressed mainly in metabolically active⁎ Corresponding author. Fax: +39 0984 492911.
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doi:10.1016/j.ygeno.2006.09.004tissues and is targeted to mitochondria through an N-terminal
peptide sequence signal for mitochondrial localization [11–13].
The Ensembl database (http://www.ensembl.org) reports a list
of putative orthologues of SIRT3 (ENSG00000142082). For
most of them a NAD-dependent deacetylase activity is reported
in the database. Interestingly, it has been recently shown that
murine Sirt3 activates mitochondrial functions and plays a
crucial role in adaptive thermogenesis in brown adipocytes [14].
Taking into account the central role played by mitochondria
[15] and lipid metabolism [16] in aging and longevity this
finding suggests that in mammals SIRT3 may play a role in the
life span similar to that of its homologous sir2 in yeast [6], the
protozoan parasite Leishmania [17], worm [7], and fly [18].
According with this hypothesis, we found that SIRT3 variability
is associated with human longevity, likely through the enhancer
activity of a VNTR (Variable Number of Tandem Repeats)
occurring in intron 5 of the gene [19,20].
The SIRT3 gene shows a head-to-head orientation (GenBank
Accession No. NT_035113) with the proteasome 26S subunit
non-ATPase 13 (PSMD13) gene, which encodes the p40.5
regulator subunit of the 26S proteasome. The 26S proteasome is
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structure composed of two complexes, a 20S core and a 19S
regulator, working as natural machinery for the degradation of
damaged proteins. Also for PSMD13 (ENSG00000185627) the
Ensembl database reports a list of putative orthologues that are
involved chiefly in the degradation of ubiquitinated proteins,
thus playing a role in cell cycle, cell cycle check point, and
DNA replication, according to Reactome, a “knowledgebase” of
biological pathways (http://www.reactome.org). The pivotal
role played by proteasome in the degradation of abnormal
proteins (for example oxidized proteins) links proteasome
function to cellular senescence [21] and aging [22]. On the
whole, we can infer that two genes that have a pivotal role in a
number of cell pathways and lie head to head within a short
chromosomal region are both related to aging and, possibly, to
life span.
The unexpected configuration of SIRT3 and PSMD13
prompted us to investigate if the PSMD13–SIRT3 intergenic
region could act as a bidirectional promoter, capable of
coordinating the expression patterns of the two genes. By
transfection experiments we discovered not only that the region
interposed between the two genes can regulate the transcription
in both directions, but also that a common core rich in Sp1 sites
plays a critical role in a shared regulatory mechanism. In
addition, we investigated whether the gene/longevity associa-
tion previously observed for SIRT3 also involved PSMD13.
The linkage disequilibrium studies presented here show that the
haplotype pool defined by PSMD13–SIRT3 variability differs
in centenarians and in younger people. Our data provide the first
evidence that two genes, both involved in aging and longevity,
could share a common regulatory mechanism.
Results
Computer-assisted analyses of the PSMD13–SIRT3 intergenic
region
Fig. 1 shows the two genes with their head-to-head
orientation and the nucleotide sequence of the 788-bp
intergenic region. Computer-assisted analyses revealed that
the region has a high G+C content (67.19%) and contains two
putative CpG islands (CpGPlot software); furthermore, the
region lacks the typical TATA box sequence and its
homologues (MatInspector software). As shown in Fig. 1B,
the region contains multiple potential DNA motifs for AP-1,
GATAs, NF-κB, and ZF5 and multiple binding sites for Sp1
factor clustered in proximity of the transcription start site of
the SIRT3 gene (+1 position in Fig. 1B, in which putative
transcription factor binding sites are marked with arrows
indicating the functional direction).
Molecular analyses of the PSMD13–SIRT3 intergenic region
By inspection of the PSMD13–SIRT3 genomic region we
observed that the PSMD13 and SIRT3 transcription start sites
are located −72 and −32 nucleotides, respectively, from the
translation initiation codons of the two genes. Therefore, thecloseness of the transcription start sites suggested to us that the
PSMD13–SIRT3 intergenic region might act as a bidirectional
promoter. Thus, to check our hypothesis and investigate the
regulation of two divergently transcribed genes, we first verified
the promoter activity of the entire intergenic region, then we
searched for the core region that was essential for transcription
in the direction of either PSMD13 or SIRT3.
The PSMD13–SIRT3 intergenic region acts as a bidirectional
promoter
We analyzed the promoter activity of the 788-bp intergenic
region by using firefly luciferase as the reporter gene. This
region was PCR-amplified from genomic DNA by using the
primers SirtFor and SirtRev (see Fig. 1B). Then, the fragment
was ligated in both directions into the promoterless pGL2-Basic
vector upstream of the luciferase coding region. Transient
transfection assays in HeLa cells revealed that the genomic
fragment of 788 bp was sufficient for the expression of the
firefly luciferase gene regardless of its orientation. Compared to
the activity of the pGL2 vector alone (Fig. 2), the PSMD13–
SIRT3 intergenic region increased the luciferase activity by a
factor of about 33 in the SIRT3 direction (p<0.0001) and about
49 in the PSMD13 direction (p<0.0001). On the whole, the
transfection results showed that the regulation of the SIRT3 and
PSMD13 gene expression could be coordinated through a
bidirectional promoter.
Deletion analyses of the regulatory promoter
To check whether SIRT3 and PSMD13 genes share a
common regulation pattern, we assembled partially deleted
constructs and checked for their promoter activity in transient
transfection experiments. In particular, we analyzed the
functional effect of the multiple Sp1 sites located close to the
transcription start site of SIRT3 (Fig. 1B) in either the SIRT3 or
the PSMD13 orientation. Deletion constructs were generated by
cloning promoter PCR fragments in both directions upstream of
the firefly luciferase gene into the pGL2-Basic vector. The
reporter plasmids were transiently transfected into HeLa cells.
The constructs, their promoter insert positions, and the cloning
primer sequences are reported in Table 1. Promoter activity of
the deletion fragments in either the SIRT3 or the PSMD13
direction was compared to that of the constructs containing the
entire bidirectional promoter (pGL2/788/SIRT3 and pGL2/788/
PSMD13 constructs). The results obtained by checking the
entire group of constructs are shown in Fig. 3 and summarized
in Table 2. In short, we see that Sp1 sites alone enhance the
activity of the promoter in the SIRT3 direction (A/SIRT3
construct) but not in the PSMD13 direction (A/PSMD13
construct). In this orientation, ZF5/NF-κB/AP-1/GATA1-2
binding sites (D/PSMD13 construct) are required to restore
the activity of the entire bidirectional promoter. However, in
both directions, the absence of Sp1 sites (B/SIRT3 and B/
PSMD13 constructs) causes a significant decrease in the
promoter activity with respect to the entire intergenic region.
On the whole, the results reported in Fig. 3 and summarized in
Fig. 1. (A) Structure of human PSMD13 and SIRT3 genes in the head-to-head orientation. The exons of the two genes are presented as filled boxes and indicated with
roman numbers. The PSMD13–SIRT3 intergenic region is presented as a hatched box. The bent arrows indicate the transcription direction. (B) Nucleotide sequence of
the 788-bp intergenic region. Translation start codons of SIRT3 and PSMD13 genes are boxed. Transcription start sites are indicated by the bent arrows. The
transcription start site of SIRT3 is designated as “+1”. Positive (negative) numbers are assigned to nucleotides downstream (upstream) of nucleotide +1. The analyzed
putative transcription factor binding sites are shown with straight arrows. SirtFor and SirtRev primers used to clone the 788-bp intergenic region are in bold.
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transcription in both directions, although synergies with further
sites are required in the PSMD13 orientation.
Linkage disequilibrium (LD) analysis
The finding that the PSMD13 and SIRT3 genes share a
common regulation path prompted us to check whether the
association we observed between longevity and SIRT3
variability was extended to the PSMD13 gene.By using the A21631G marker of PSMD13, and the G477T
and VNTRintron5 markers of SIRT3, we carried out pairwise LD
analyses in a sample of 710 unrelated subjects (seeMaterials and
methods). We found statistically significant LD values (like-
lihood-ratio test) for all the pairs of markers (A21631GPSMD13
and VNTRSIRT3 p=0.001; A21631GPSMD13 and G477TSIRT3
p=0.001; G477TSIRT3 and VNTRSIRT3 p=0.002). Therefore,
the linkage disequilibrium spans across the entire region
depicted in Fig. 1A and involves the markers of both
PSMD13 and SIRT3.
Fig. 2. Luciferase expression of pGL2/788/SIRT3 and pGL2/788/PSMD13
constructs reported as fold induction with respect to the pGL2-Basic vector.
pGL2/788/SIRT3 and pGL2/788/PSMD13 contain the intergenic region in the
SIRT3 and PSMD13 orientation, respectively. The values reported for
transfection experiments are the means±standard deviation of three independent
duplicate experiments. The statistical significance of the differences between the
promoter activity of the two constructs was tested by ANOVA and LSD post hoc
tests.
Table 1
Deletion constructs, their promoter inserts, and cloning primers
Deletion
construct
Promoter insert
positions
Cloning primer sequences (5′→3′)
A/SIRT3 −145 to +169 ctcggtaccGCCGGAGGCGTCGGCAAG
A/PSMD13 −169 to +145 ctcggtaccATCGTCCCTGCCGCCAAGCA
B/SIRT3 −619 to –128 ctcggtaccGCTCACTCACTTCCGGCGCCGA
B/PSMD13 +128 to +619 ctcggtaccCTTGCCGACGCCTCCGGC
C/SIRT3 −174 to +169 ctcggtaccTCTACTCGCCTCTACGTC
C/PSMD13 −169 to +174 ctcggtaccATCGTCCCTGCCGCCAAGCA
D/SIRT3 −201 to +169 ctcggtaccGATGAGACACCAGACT
D/PSMD13 −169 to +201 ctcggtaccATCGTCCCTGCCGCCAAGCA
The 9-bp cloning adaptor is represented by lowercase characters. Promoter insert
positions are related to the intergenic sequence in the SIRT3 (A/SIRT3, B/
SIRT3, C/SIRT3, D/SIRT3) and PSMD13 (A/PSMD13, B/PSMD13, C/
PSMD13, D/PSMD13) orientations.
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changed in the population according to age, the sample was
divided into two subsamples, the first made of 18- to
90-year-old individuals (n=615), the second made of 91- to
108-year-old individuals (n=95). The cut-off between age
classes was chosen on the consideration that such a cut-off
corresponds approximately to the surviving upper 0.1% of
the population under study (Calabria, southern Italy). Table 3
shows the haplotype distribution in the two age groups. The
exact test of population differentiation between the two
subsamples revealed a significant difference between the
haplotype pools (p=0.019). Therefore, as the population ages
and survival selection operates, some haplotypes are
preferentially lost from the haplotype pool (see for example
the haplotype GG2 in Table 3), while others increase their
frequency (see for example the haplotype AG4 in Table 3).
On the whole, the haplotype analysis revealed that the
chromosomal region associated with longevity comprises also
the PSMD13 gene.
Discussion
By exploring the neighborhood of the SIRT3 gene we
observed that the PSMD13 gene lies very close to it (788 bp) in
a head-to-head configuration. It was recently suggested that
closely located bidirectional gene pairs whose transcription start
sites are separated by less than 1 kb are common in the human
genome and that such a bidirectional organization may control
genes functionally related to each other [23–25]. Accordingly,
the genes PSMD13 and SIRT3 could be functionally related.
What is more, according to GenBank (http://www.ncbi.nlm.nih.
gov/MapViewer) the head-to-head organization of the two
genes is evolutionarily conserved in bird, rat, mouse, dog,
chimpanzee, and human. Interestingly, the distance between the
two genes increases throughout evolution (14 bp in Gallus
gallus, 56 bp in Rattus norvegicus, 86 bp in Mus musculus,
157 bp in Canis familiaris, 555 bp in Pan troglodytes, where
the regulatory sites display the same pattern as in humans, and
788 bp in Homo sapiens). This observation is intriguing, as itsuggests an increasing complexity throughout evolution of a
putative coregulation machinery shared between the two genes.
The aim of our work was: (a) to verify the bidirectional
promoter activity of the PSMD13–SIRT3 788-bp intergenic
region, (b) to identify a common regulation core in the promoter
region, and (c) to verify whether the association with the
longevity trait previously observed for SIRT3 [19,20] involved
PSMD13, too.
Bioinformatics analyses showed that the region is character-
ized by a GC content of 67% and comprises two CpG islands.
These structural features are consistent with the findings that
almost all the bidirectional promoters in mammalian genomes
have a median GC content of 66%, and 77% of them are located
in CpG islands [23,24,26]. The results of transfection experi-
ments carried out by expression constructs containing the entire
788-bp intergenic region cloned in both PSMD13 and SIRT3
directions (Fig. 2) confirmed that such a region acts as a
bidirectional promoter. Therefore we can give a positive answer
to question (a).
As shown in Fig. 1B, the intergenic region contains a number
of putative transcription factors binding sites such as AP-1,
GATAs, NF-κB, ZF5, and Sp1. In particular, the GC boxes that
bind Sp1 factors are clustered in proximity of the SIRT3
transcription start site. A TATA box is absent. The lack of a
TATA box is characteristic of the so-called housekeeping genes,
but it was also observed in bidirectional promoters [26]. On the
other hand, the presence of GC boxes close to the transcription
start site is characteristic not only of TATA-less promoters, for
which Sp1 factors are generally responsible for fixing the
transcription start site, but also of bidirectional promoters
[27,28]. By carrying out a series of transient transfection
experiments with a set of deletion constructs (Table 1) cloned in
both orientations, we discovered that Sp1 sites play a critical role
in regulating gene expression in both directions (Fig. 3 and Table
2), although they act alone in the SIRT3 orientation but in
association with other transcription factors in the PSMD13
orientation. In line with this observation, it has been documented
that Sp1 factors may act in combination with other coactivator or
corepressor factors to modulate transcription by physical or
functional interaction [29,30]. On the whole, the entire set of
results summarized in Table 2 suggests that PSMD13 and SIRT3
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and other regulatory factors (for example ZF5) in the co-
regulation of the two genes will be provided by appropriateFig. 3. Deletion analysis of the human PSMD13–SIRT3 bidirectional transcription c
region and the constructs containing promoter fragments in the (A) SIRT3 and (B) PS
the right, the activity of each construct is shown as fold induction with respect to th
means±standard deviation of three independent duplicate experiments.further experiments (for example gel-shift and mutagenesis
experiments), which we are planning right now. In any case, on
the basis of the results here presented, we can say that a fineontrol region. On the left, the construct containing the whole 788-bp intergenic
MD13 orientation are shown with putative transcription factor binding sites. On
e pGL2-Basic vector. The values reported for transfection experiments are the
Table 2
Synoptic table summarizing the results of the transfection experiments shown in Fig. 3
Deletion construct Transcription regulatory elements Transcription activity with respect
to the entire promoter
p value
A/SIRT3 Multiple Sp1 binding sites only Up-regulation 0.001
A/PSMD13 Down-regulation 0.000
B/SIRT3 Absence of multiple Sp1 binding sites Down-regulation 0.000
B/PSMD13 Down-regulation 0.000
C/SIRT3 Multiple Sp1 binding sites plus two ZF5 binding sites Down-regulation 0.001
C/PSMD13 Down-regulation 0.001
D/SIRT3 Multiple Sp1 binding sites plus two ZF5 binding sites and
NF-κB/GATA1 binding sites
Down-regulation 0.013
D/PSMD13 Same activity 0.156
The p values refer to the null hypothesis of no difference between the transcription activity of the entire 788-bp promoter and the transcription activity of the deletion
construct (ANOVA and LSD post hoc tests).
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concerted expression of the two genes (question (b)).
Finally, through pairwise linkage disequilibrium analyses
carried out between markers of PSMD13 and SIRT3 in a
population sample including centenarians (Table 3), we showed
that the entire chromosomal region encompassing the two genes
is associated with the longevity phenotype (question (c)).
The observation that PMSD13 and SIRT3 share a bidirec-
tional promoter (and that this architecture is conserved along
evolution) is very interesting given that both genes are involved
in aging. Usually, when more genes are clustered in the genome,
their organization is selected relative to a possible complex
phenotype to which such genes contribute. It would be
surprising if this phenotype was aging, since several theories
support the idea that aging is not a programmed and adaptive
process, but a process due mainly to accumulation of stochastic
mutations and that longevity is due, at most, to antagonist
pleiotropic phenomena [3,4]. On the other hand, recent studiesTable 3
PSMD13–SIRT3 haplotype pools in 18- to 90- and 91- to 108-year-old subjects
Haplotype 18- to 90-year-old
subjects (n=615)
91- to 108-year-old
subjects (n=95)
RF (%) SE RF (%) SE
AG1 2.0 0.4 1.1 0.8
GG1 11.3 0.9 10.1 2.2
AT1 0.4 0.2 0.0 0.0
GT1 28.4 1.3 29.3 3.2
AG2 0.3 0.2 1.6 1.0
GG2 10.1 0.9 4.7 1.6
GT2 0.4 0.2 0.5 0.6
AG3 2.0 0.4 2.6 1.2
GG3 19.6 1.2 18.3 2.9
GT3 0.1 0.1 0.6 0.6
AG4 22.8 1.2 28.6 3.3
GG4 0.9 0.3 1.6 0.9
AT4 0.2 0.1 0.0 0.0
GT4 0.2 0.1 0.0 0.0
AG5 0.4 0.2 1.0 0.7
GG5 0.2 0.1 0.0 0.0
AG6 0.7 0.2 0.0 0.0
The markers used for haplotype analysis are the following (in order): A21631G
for PSMD13, G477T and 1–6 VNTRintron5 for SIRT3. Haplotype relative
frequencies (RF) and standard errors (SE) are ×100.show that gene order in eukaryotic genomes is not completely
random, but that genes with comparable and/or coordinated
expression tend to be clustered together [31,32]. On the basis of
this, the evidence for a common regulation between SIRT3 and
PSMD13 genes is very intriguing considering that the two genes
contribute to the same phenotype. However, it is still under
discussion whether coexpressed genes have been linked
together by natural selection to facilitate their expression or
whether the genes are coexpressed simply because of their
physical proximity in the genome. Several studies show that
natural selection acts to preserve linked pairs of coexpressed
genes [33,34]. Indeed, adjacent pairs of essential genes are
preferentially conserved along evolution. The close proximity
of the genes could be an adaptation that facilitates the
coregulation of their transcription. It was observed that
coexpressed genes remain linked more often than expected,
which indicates that selection might favor their retention as a
pair. It was also found that clusters of essential genes are in
regions of low recombination and that larger clusters have lower
recombination rates [35]. The selection could act to modify both
the intragenomic variation in the recombination rate and the
distribution of genes, thus determining the coevolution of gene
order and recombination rate. A landmark in this field could be
a recently published paper that reports results on head-to-head
gene organization [36]. The authors carried out a systematic
investigation of bidirectional gene pairs, focussing on structural
features, evolutionary conservation, expression correlation, and
functional association. The conclusion was that the head-to-
head gene organization is ancient and conserved and may
provide a fine mechanism of transcriptional coregulation based
on gene organization. In particular, by comparing 42 head-to-
head human gene pairs to their orthologue pairs in chicken and
Fugu, the authors identified 10 pairs (20 genes) for which
important conserved functions could be assumed: the
PSMD13–SIRT3 gene pair was one of them.
These considerations suggest an intriguing question: why did
“Mother Nature” conserve a common pathway of regulation
between two genes involved in a process that is believed to have
come out of natural selection? It has been recently proposed that
a programmed and altruistic aging may occur in higher
eukaryotes [5]. Our findings are in line with this idea, although
the deep evolutionary force that has driven such an architecture
along evolution needs to be explored.
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Molecular analyses of the PSMD13–SIRT3 intergenic region
Bioinformatic analyses
The GC content of the 788-bp common 5′ region shared by the SIRT3 and
PSMD13 genes and detection of areas rich in CpG islands were performed using
CpGPlot software (http://bioweb.pasteur.fr/seqanal/interfaces/cpgplot/html).
Prediction of putative transcriptional factor binding sites was performed using
MatInspector software (http://www.genomatix.de/matins).
Construction of reporter gene plasmids
The 788-bp PSMD13–SIRT3 intergenic region was PCR amplified from
human genomic DNA by using the forward primer SirtFor and the reverse
primer SirtRev (Fig. 1B). The primers contained a 9-bp cloning adaptor with a
KpnI restriction site. The PCR was carried out in 100 μl of a mix consisting of
1× buffer, 100 mM dNTPs, 500 nM primers, 1.5 mM MgCl2, and 5 U of
DNAzyme (Finnzyme). The reaction consisted of 25 cycles, each cycle
consisting of a denaturation step (94°C for 60 s), an annealing step (55°C for
60 s), and an extension step (72°C for 60 s). The first cycle was preceded by a
denaturation step of 1 min at 94°C and the last one was followed by an extension
step of 3 min at 72°C. The resulting 788-bp fragment was purified by agarose gel
electrophoresis (Wizard SV Gel; Promega) and digested with KpnI enzyme
(Promega) as recommended by the manufacturer. After enzyme digestion, the
fragment was inserted using T4 DNA ligase (Promega) in both orientations into
the KpnI site upstream of the firefly luciferase reporter gene in the pGL2-Basic
vector (Promega), yielding two plasmids, pGL2/788/SIRT3 (intergenic region in
SIRT3 orientation) and pGL2/788/PSMD13 (intergenic region in PSMD13
orientation). DNA was transformed into Top10 Escherichia coli cells by
electroporation according to standard protocols. pGL2/788/SIRT3 and pGL2/
788/PSMD13 constructs were prepared using the Wizard Plus SV Minipreps
DNA purification system (Promega). The constructs were sequenced with the
BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE Applied
Biosystems) to check the correct insert orientation and to confirm that the
sequences matched the original genomic sequences without PCR-generated
errors.
Deletion analyses
Deletion constructs were generated by PCR amplification of promoter
fragments by using as template the reporter plasmids pGL2/788/SIRT3. The
constructs, their promoter inserts, and the cloning primers are reported in
Table 1. The primers contained a 9-bp cloning adaptor with a KpnI
restriction site. PCR was carried out as described above. After enzyme
digestion, PCR products were purified by agarose gel electrophoresis and
then inserted in both orientations into the KpnI-linearized pGL2-Basic. All
the plasmids were sequenced to check the correct insert orientation and to
confirm the sequence.
Promoter analysis by luciferase assay
HeLa cells were cultured in Dulbecco's modified Eagle's medium
(Invitrogen) containing 4.5 g/L glucose and 2 mM L-glutamine supplemented
with 5% fetal bovine serum (Invitrogen) and 1% penicillin/streptomycin
(Invitrogen). The cells were cultured in a water-humidified incubator at 37°C
in 5% CO2/95% air. HeLa cells (1×10
5) were transferred into 24-well plates
with 500 μl of regular growth medium/well the day before transfection.
Transfections were performed with the Fugene6 reagent as recommended by
the manufacturer (Roche Molecular Biochemicals) with a mixture containing
1 μg of each reporter plasmid and 2 ng of pRL-CMV (Promega), a plasmid
that contains the Renilla luciferase gene under the cytomegalovirus promoter
and is utilized as an internal control to normalize the effects of transfection
efficiencies. Cells were lysed 24 h after transfection by applying 50 μl
Passive Lysis Buffer of the Dual Luciferase Reporter Assay Kit (Promega)
into each well of the 24-well plate. Twenty microliters of cell lysate was used
for luciferase reporter assay by using the same kit according to the
manufacturer's protocol. Light intensity was quantified in a Lumat LB9507
luminometer (EG&G Berthold). The luciferase activity of the reporter
plasmids was normalized to the Renilla luciferase activity. Each transfection
experiment was carried out three times in duplicate. ANOVA and LSD posthoc tests were used to check the significance of the difference between the
fold induction value of the deleted construct and that of the construct
containing the entire 788-bp PSMD13–SIRT3 intergenic region.
Population genetic analyses
Population sample
A population sample of 710 subjects was analyzed. All the subjects lived in
Calabria (southern Italy) and their origin in the area had been ascertained up to
the grandparents' generation (interview). The sample consisted of two
subsamples: one included 18- to 90-year-old subjects (615 subjects, 262
males and 353 females), the other 91- to 108-year-old subjects (95 subjects, 31
males and 64 females). The younger group had been collected between 2000 and
2003 by an appropriate campaign addressed to Calabria University students and
staff and to people who attended the University for the Elderly or used local
thermal baths. The older group had been collected in the same period by
consulting the Population Registers of the Municipalities of Calabria, contacting
the potential probands by phone, and then visiting them in the case of positive
answer to a first contact. After a detailed explanation of the aims of the genetic
studies on aging carried out by our research group, the subjects who agreed to
participate gave us a written informed consent and donated a blood sample for
routine laboratory analyses and DNA preparation. People older than 60 years
underwent a complete clinical and geriatric assessment. Subjects free of
clinically overt pathologies and having blood and biochemical parameters in the
normal age- and sex-specific range were enrolled in the study. In particular, the
subjects in the older group belonged to the health categories A and B previously
described [37].
DNA analyses
All the genotype data relevant to the G477T marker of SIRT3 [14] and to the
VNTRintron5 marker of SIRT3 [15] were already included in our database.
Therefore DNA analyses were carried out only for genotyping PSMD13
variability.
The A21631G marker located in exon 1 (position 21631) of the PSMD13
gene (GenBank Accession No. AC136475) was analyzed by PCR and SacI
restriction analysis. A 465-bp fragment was amplified from genomic DNA
(extracted from blood buffy coats) in 25 μl of reaction mixture containing
200 mM each dNTP, 0.5 μM both forward (5′-GACATCCCGGTTGTT-
CTTCTG-3′, nt 21551, GenBank Accession No. AC136475,) and reverse (5′-
CTACTCCTGAACCGTTTTAGT-3′, nt 22015, GenBank Accession No.
AC136475,) primers, 1.5 mM MgCl2, 1× polymerase buffer, 1 unit of EuroTaq
DNA polymerase (EuroClone). The PCR consisted of 30 cycles, each cycle
consisting of a denaturation step (95°C for 60 s), an annealing step (55°C for
60 s), and an extension step (72°C for 60 s). The first cycle was preceded by a
denaturation step of 45 s at 95°C and the last one was followed by an extension
step of 7 min at 72°C. A 20-μl amount of amplified DNA was digested by the
restriction enzyme SacI (5 U) for 3 h at 37°C as recommended by the
manufacturer. The fragments were separated by electrophoresis on a 2.5%
agarose gel and stained with ethidium bromide. The 465-bp PCR fragment
contains two SacI restriction sites, one of them is not polymorphic and produces
two fragments of 341 and 124 bp. The SacI polymorphic site is located within
the 124-bp fragment. The presence of the G base in this site (GAGCTC)
produces two fragments of 43 and 81 bp.
Haplotype analyses
Allele frequencies of single markers were computed by gene counting
from the observed genotypes, and Fisher's exact test was applied to verify
Hardy–Weinberg equilibrium [38]. Pairwise LD analyses were carried out on
marker A21631G of PSMD13 and markers G477T and VNTRintron5 of
SIRT3 [19,20]. LD between pairs of markers was tested by a likelihood-ratio
test. As for genotype data with unknown haplotype phase, an empirical
distribution of haplotype frequencies obtained by a permutation procedure
was utilized [39].
Population haplotype frequencies were estimated by maximum-likelihood
estimation [38,40]. The null hypothesis of no difference between haplotype
pools in the two age groups (18- to 90- and 91- to 108-year-old subjects) was
checked by ad hoc exact test [41]. All the statistical analyses were carried out by
means of Arlequin 2.0 software.
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